M. S. Lim

COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications

M. S. Lim, S. Mcrae, 2021, Critical Reviews in Oncology/Hematology.

Age‐adjusted cut‐off using the IL D‐dimer HS assay to exclude pulmonary embolism in patients presenting to emergency

M. S. Lim, S. Chunilal, A. Bennett, 2018, Internal medicine journal.

Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort Study

E. Wood, Z. McQuilten, N. Chan, 2018, Seminars in Thrombosis and Hemostasis.

Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivo patient samples.

M. S. Lim, S. Mcrae, Archna Sharma, 2022, Pathology.

Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism

D. Nandurkar, M. S. Lim, S. Chunilal, 2019, Journal of Thrombosis and Thrombolysis.

Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia

M. S. Lim, Muhajir Mohamed, 2024, Internal medicine journal (Print).